NLM Logo

6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one MeSH Supplementary Concept Data 2024


MeSH Supplementary
6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one
Unique ID
C074923
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C074923
Entry Term(s)
(+)(-)-FEMEPPEP
(+)-FEMEPPEP
6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one, (+)(-)-isomer
FEMEPPEP
Registry Number
141117-01-3
Related Numbers
141116-96-3
Heading Mapped to
*Pyrazoles
*Pyridines
Frequency
1
Note
structure given in first source; more potent than lovastatin in inhibiting cholesterol biosynthesis; RN refers to the (+)-isomer
Source
J Med Chem 1992 May 29;35(11):2095-2103
Date of Entry
1992/07/06
Revision Date
2001/07/17
6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one Preferred
(+)-FEMEPPEP Narrower
6-(2-(5-(4-fluorophenyl)-3-(1-methylethyl)-1-(2-pyridinyl)-1H-pyrazol-4-yl)ethenyl)tetrahydro-4-hydroxy-2H-pyran-2-one, (+)(-)-isomer Narrower
page delivered in 0.006s